Perrigo Rolls Out US ProAir Rival
Launches ‘Limited Quantity’ After FDA Nod And Ramps Up Production
Perrigo has received US FDA approval for a generic version of Teva’s ProAir albuterol inhaler. The firm is immediately launching a “limited quantity” but is also ramping up production with partner Catalent to meet future demand.
